Active surveillance in intermediate risk prostate cancer: is it safe?

被引：0
|
作者：
Krishnananthan, Nishanth [1 ]
Lawrentschuk, Nathan [1 ,2 ,3 ]
机构：
[1] Univ Melbourne, Austin Hlth, Dept Surg, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Surg Oncol, Melbourne, Vic, Australia
[3] Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia
来源：
INTERNATIONAL BRAZ J UROL | 2016年 / 42卷 / 03期
关键词：
Prostatic Neoplasms; Prostate cancer; familial [Supplementary Concept; Watchful Waiting; Disease; Therapeutics; RADICAL PROSTATECTOMY; MEN; OUTCOMES; MANAGEMENT; GUIDELINE; COHORT;
D O I：
10.1590/S1677-5538.IBJU.2016.03.04
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：418 / 421
页数：4
相关论文
共 50 条
  • [41] Active surveillance for favorable-risk prostate cancer: What are the results and how safe is it?
    Laurence Klotz
    [J]. Current Urology Reports, 2007, 8 (5) : 341 - 344
  • [42] Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
    Pepe, Pietro
    Pepe, Ludovica
    Pennisi, Michele
    Fraggetta, Filippo
    [J]. IN VIVO, 2024, 38 (03): : 1300 - 1305
  • [43] Intermediate Risk Prostate Cancer and Active Surveillance: Maximize Utilization while Minimizing Failure
    Kibel, Adam S.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (03): : 493 - 495
  • [44] Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance CON
    Tosoian, Jeffrey J.
    Carter, H. Ballentine
    [J]. JOURNAL OF UROLOGY, 2017, 198 (05): : 997 - 998
  • [45] IS FAVORABLE INTERMEDIATE RISK PROSTATE CANCER REALLY FAVORABLE? IMPLICATIONS FOR ACTIVE SURVEILLANCE STRATEGIES
    Haywood, Samuel
    Nyame, Yaw
    Liang, Helen
    Klein, Eric
    Stephenson, Andrew
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1055 - E1055
  • [46] Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance PRO
    Sanda, Martin G.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (05): : 998 - 999
  • [47] Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance
    Dall'Era, Marc A.
    Davies, Benjamin J.
    [J]. EUROPEAN UROLOGY FOCUS, 2015, 1 (02): : 208 - 209
  • [48] Active surveillance in low risk prostate cancer
    Bozkurt, Ozan
    Demir, Omer
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 76 - 79
  • [49] Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy
    Patel, Hiten D.
    Gupta, Mohit
    Tosoian, Jeffrey J.
    Carter, H. Ballentine
    Partin, Alan W.
    Epstein, Jonathan I.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (05): : 1068 - 1074
  • [50] Active surveillance for low risk prostate cancer
    Gnanappiragasam, S.
    Forde, J. C.
    Moloney, M.
    Kiely, S.
    Walsh, K.
    Durkan, G. C.
    [J]. BJU INTERNATIONAL, 2014, 114 : 24 - 24
12345